Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Q2 2024 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Aug 07, 2024 / 09:00PM GMT
Release Date Price: $9.1 (+0.11%)
Editor

Please stand by for streaming text. Thank you for standing by, and welcome to the marvelous Life Sciences Second Quarter 2024 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you'd like to ask a question, simply press star, followed by the number one on your telephone keypad. If you will, to withdraw your question again, press the star one. Thank you. I'd now like to turn the call over to Debra Hart, Head of Investor Relations. You may begin.

Debra Hart
Maravai LifeSciences Holdings, Inc - Senior Director of IR

Good afternoon, everyone. Thanks for joining us on our second quarter 2024 earnings call. Our press release and the slides accompanying today's call are posted on our website and available at investors dot Marvell.com. You can see on our agenda for today on Slide 2 for Kay will provide a business update, and Kevin will review our financial results and guidance through Birch President of nucleic acid production that he buys CEO, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot